Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 6 de 6
Filter
1.
Zhong Yao Cai ; 32(2): 179-82, 2009 Feb.
Article in Zh | MEDLINE | ID: mdl-19504956

ABSTRACT

OBJECTIVE: To observe the effects of pilose antler and antler glue on osteoporosis of ovariectomized rats. METHODS: 60 6-month-old female rats were divided randomly into sham-operated group, model group, the positive group, pilose antler high-dose group, pilose antler low-dose group and antler glue group. We extracted bilateral ovaries to establish osteoporosis model and treated at two weeks postoperationally for consecutively 13 weeks, then observed the effects of pilose antler and antler glue on rat bone mineral density, bone mineral content, serum biochemical indicators, bone tissue morphology and other indicators. RESULTS: After 13 weeks, the high-dose group and antler glue group could significantly improve the BMD and bone mineral content of the ovariectomized rats, reduce BGP and ALP content, and remarkably increase the width of trabecula bone and bone trabecula area percentage, increase osteoblasts significantly, and decrease osteoclast cells significantly. Pilose antler low-dose also had the phenomenon above, but the result was not so good as high-dose group. CONCLUSION: Pilose antler and antler glue can antagonize osteoporosis of the ovariectomized rats.


Subject(s)
Antlers , Bone Density/drug effects , Materia Medica/pharmacology , Osteoporosis/pathology , Alkaline Phosphatase/blood , Animals , Calcium/blood , Collagen , Deer , Disease Models, Animal , Female , Materia Medica/administration & dosage , Osteoblasts/drug effects , Osteocalcin/blood , Osteoclasts/drug effects , Osteoporosis/blood , Osteoporosis/etiology , Ovariectomy , Quinestrol/administration & dosage , Quinestrol/pharmacology , Random Allocation , Rats , Rats, Wistar
2.
Zhongguo Zhong Yao Za Zhi ; 31(3): 228-31, 2006 Feb.
Article in Zh | MEDLINE | ID: mdl-16573005

ABSTRACT

OBJECTIVE: To study the effects of Yifuning soft gelatin capsules (YFN) on pathology and biomechanical indexes of ovariectomied female rats. METHOD: Sixty female Sprague-Dawley rats without pregnancy and delivery were used,50 of them were ovariectomized and randomly divided into 5 groups: ovariectomy(OVX), OVX with diethylstilbestrol tables (DT), OVX with YFN (high dose,middle dose and low dose), the others were sham-operated group. The rats began to take the rats drugs in the fifth week after the operation. After 12 weeks of treat ment the rats were killed, and the bones were collected to inspect. The pathology of bone was observed with the HE stain and the area of trabecular was detected. The electronic testing device was used to detect the biomechanical properties. RESULT: The results indicated that the rat model of postmenopausal osteoporosis (PMO) was a success. Compared with the model group, after application of the drugs, the observation of HE showed different repairing around trabecular. The biomechanical parameters also increased significantly. CONCLUSION: YFN can effectively prevent the loss of bone in OVX rats and strengthen bone quality, and has a good effect on PMO oostmenopausal osteoporosis.


Subject(s)
Materia Medica/pharmacology , Oils, Volatile/pharmacology , Osteoporosis , Animals , Biomechanical Phenomena , Bone Density , Capsules , Curcuma/chemistry , Drug Combinations , Female , Femur/physiopathology , Lumbar Vertebrae/physiopathology , Materia Medica/administration & dosage , Materia Medica/isolation & purification , Oils, Volatile/administration & dosage , Oils, Volatile/isolation & purification , Osteoporosis/pathology , Osteoporosis/physiopathology , Ovariectomy , Oviducts/chemistry , Plants, Medicinal/chemistry , Random Allocation , Ranidae , Rats , Rats, Sprague-Dawley
3.
Zhongguo Zhong Yao Za Zhi ; 30(12): 919-22, 2005 Jun.
Article in Zh | MEDLINE | ID: mdl-16124611

ABSTRACT

OBJECTIVE: To study the effects of Yifuning soft capsules on postmenopausal osteoporosis in ovariectomized female rats. METHOD: 60 female sprague-dawley rats in 3-month were used, 50 of them were ovariectomized and randomly divided into 5 groups: ovariectomy (OVX), OVX with diethylstilbestrol tables (DT), OVX with YFN (high dose, middle dose and low dose), the others were sham-operated group. Began to give the rats drugs in the fifth week after the operation. After 12 weeks killed the rats. The blood,the uterus and bones were collected to inspect. The content of estrogen (E2) in serum was detected by radioimmunoassay method. The contents of Ca, P, ALP in serum were detected using the automic biochemistry-analyse device. The uterus were weight and the length, width, dry weight and net weight of the shoulder bone were measured. The contents of Ca, Mg, Zn, Mn in the bone were measured using the automic absorption spectrophotometer. The right femer and the third lumbar vertebra were detected for BMD using the dual-energy X-ray absorptiometry scanner and compression test using electronic testing device. RESULT: After using the drugs,the content of E2, Ca in serum, the weight of uterus, the contents of Ca, Mg, Zn, Mn in the bone and the BMD of right femer increased significantly, the content of P, ALP in serum decreased significantly. CONCLUSION: Yifuning soft capsules has a good effect on postmenopausal osteoporosis, which provides evidence for clinical use.


Subject(s)
Bone and Bones/metabolism , Drugs, Chinese Herbal/pharmacology , Estradiol/blood , Materia Medica/pharmacology , Osteoporosis/metabolism , Animals , Bone Density/drug effects , Capsules , Curcuma/chemistry , Drug Combinations , Drugs, Chinese Herbal/isolation & purification , Female , Materia Medica/isolation & purification , Osteoporosis/pathology , Ovariectomy , Plants, Medicinal/chemistry , Rana temporaria , Random Allocation , Rats , Rats, Sprague-Dawley
4.
Expert Opin Ther Targets ; 6(1): 57-72, 2002 Feb.
Article in English | MEDLINE | ID: mdl-11901481

ABSTRACT

The thymus provides an optimal cellular and humoral microenvironment for a cell line committed differentiation of haematopoietic stem cells. The immigration process requires the secretion of at least one peptide, called thymotaxin, by cells of the reticulo-epithelial (RE) network of the thymic stromal cellular microenvironment. The thymic RE cells are functionally specialised based on their intrathymic location and this differentiation is modulated by various interaction signals of differentiating Thymocytes and other nonlymphatic, haematopoietic stem cells. The subcapsular, endocrine, RE cell layer is comprised of cells filled with periodic acid Shiff's-positive granules, which also express A2B5/TE4 cell surface antigens and MHC Class I (HLA A, B, C) molecules. Thymic nurse cells also produce thymosins beta 3 and beta 4 and display a neuroendocrine cell specific immunophenotype (IP): Thy-1+, A2B5+, TT+, TE4+, UJ13/A+, UJ127.11+, UJ167.11+, UJ181.4+ and presence of common leukocyte antigen (CLA+). Cortical RE cells express a surface antigen, gp200-MR6, which plays a significant role of thymocyte differentiation. Medullar RE cells display MHC Class II (HLA-DP, HLA-DQ, HLA-DR) molecule restriction. Thymic RE cells also produce numerous cytokines that are important in various stages of haematopoietic cell activation and differentiation. The co-existence of pituitary hormone and neuropeptide secretion, as well as the production of a number of interleukins and growth factors, and expression of receptors for all, by RE cells is an unique molecular biological phenomenon. Thymic neuroendocrine polypeptides are the source of self antigens presented by the MHC molecules to differentiating haematopoietic stem cells. On the level of individual RE cells, the numerous projections associated with a single cell, which engulf developing lymphocytes, nurturing and guiding them in their maturation, may differ in their hormone production and/or hormone receptor expression profile, thus allowing a single cell to be involved in distinct, separate steps of the T-cell and other haematopoietic cell maturation process. Thymic RE cells represent an important cellular and humoural network within the thymic microenvironment and are involved in the homeopathic regulation mechanisms of the multicellular organism. The intrathymic T-lymphocyte selection is a complex, multistep process, influenced by several functionally specialised RE cells and under immuno-neuroendocrine regulation control reflecting the dynamic changes of the mammalian organism.


Subject(s)
Bone and Bones/pathology , Osteoporosis/drug therapy , Animals , Bone and Bones/drug effects , Bone and Bones/metabolism , Bone and Bones/physiology , Humans , Lipid Metabolism , Osteoporosis/metabolism , Osteoporosis/pathology , Peptides/therapeutic use , Steroids/therapeutic use
5.
Braz Oral Res ; 20(3): 196-201, 2006.
Article in English | MEDLINE | ID: mdl-17119700

ABSTRACT

Osteoporosis, a disease characterized by progressive bone loss, has been the target of several studies in the past few years. It results in a much higher risk for fractures and might cause slower bone lesion healing. The aim of this work was to study the effects of Risedronate (allopathic medicine) and Calcarea phosphorica 6CH (homeopathic medicine) on the repair of bone lesions in male rats with osteoporosis induced by castration. Eighty-four three-month-old rats were used divided into four groups of twenty-one animals each. Three groups where castrated and one group was submitted to Sham surgery. One month later, cortical lesions were made in all animals' tibiae and, after one day, the different experimental treatments began according to the following groups: CR--castrated/Risedronate (1 mg/kg/day); CCp--castrated/Calcarea phosphorica 6CH (3 drops/day); CP--castrated/placebo and SP--Sham/placebo. The animals were sacrificed at seven, fourteen and twenty-eight days after the beginning of the treatments and had their tibiae removed. Digital radiographs of the tibiae were taken and analyzed in order to evaluate the optical density of the defect area. Then, they were decalcified and processed for histological and histomorphometrical analysis. The data were submitted to ANOVA, and to the Tukey and Dunnett tests (5%). The allopathic and homeopathic treatments led to different bone formation as regards remodeling and maturation aspects. Further research is necessary to access the resistance and quality of the newly formed bone.


Subject(s)
Bone Density Conservation Agents/therapeutic use , Bone Remodeling/drug effects , Calcium Phosphates/therapeutic use , Etidronic Acid/analogs & derivatives , Osteoporosis/drug therapy , Phytotherapy , Analysis of Variance , Animals , Bone Density/drug effects , Calcium Phosphates/pharmacology , Disease Models, Animal , Etidronic Acid/therapeutic use , Male , Orchiectomy , Osteoporosis/pathology , Plant Preparations , Rats , Risedronic Acid
6.
Braz. oral res ; 20(3): 196-201, Jul.-Sept. 2006. ilus, graf
Article in English, Portuguese | LILACS | ID: lil-435806

ABSTRACT

Osteoporosis, a disease characterized by progressive bone loss, has been the target of several studies in the past few years. It results in a much higher risk for fractures and might cause slower bone lesion healing. The aim of this work was to study the effects of Risedronate (allopathic medicine) and Calcarea phosphorica 6CH (homeopathic medicine) on the repair of bone lesions in male rats with osteoporosis induced by castration. Eighty-four three-month-old rats were used divided into four groups of twenty-one animals each. Three groups where castrated and one group was submitted to Sham surgery. One month later, cortical lesions were made in all animals' tibiae and, after one day, the different experimental treatments began according to the following groups: CR - castrated/Risedronate (1 mg/kg/day); CCp - castrated/Calcarea phosphorica 6CH (3 drops/day); CP - castrated/placebo and SP - Sham/placebo. The animals were sacrificed at seven, fourteen and twenty-eight days after the beginning of the treatments and had their tibiae removed. Digital radiographs of the tibiae were taken and analyzed in order to evaluate the optical density of the defect area. Then, they were decalcified and processed for histological and histomorphometrical analysis. The data were submitted to ANOVA, and to the Tukey and Dunnett tests (5 percent). The allopathic and homeopathic treatments led to different bone formation as regards remodeling and maturation aspects. Further research is necessary to access the resistance and quality of the newly formed bone.


A osteoporose, doença caracterizada pela perda de massa óssea, tem sido alvo de estudos nos últimos anos. Fraturas decorrentes da osteoporose são muito comuns e podem apresentar consolidação mais lenta. O objetivo deste trabalho foi avaliar o efeito do risedronato (medicamento alopático) e da Calcarea phosphorica 6CH (medicamento homeopático) no reparo de lesões ósseas em ratos com osteoporose induzida por castração. Para tanto, foram utilizados oitenta e quatro ratos, com três meses de idade, separados em quatro grupos de vinte e um animais, sendo três grupos submetidos à castração e um grupo a falsa cirurgia ("Sham"). Um mês após a cirurgia, foram realizadas lesões corticais na tíbia de todos os animais e, a partir do dia seguinte, os tratamentos experimentais foram iniciados de acordo com os seguintes grupos: CR - castrado/risedronato (1 mg/kg/dia); CCp - castrado/Calcarea phosphorica 6CH (três gotas/dia); CP - castrado/placebo e SP - "sham"/placebo. Os animais foram sacrificados aos sete, catorze e vinte e oito dias após o início do tratamento e as tíbias foram removidas. Radiografias digitais foram realizadas e avaliadas para obter a densidade óptica na área do defeito. Em seguida, foram descalcificadas e processadas para análise histológica e histomorfométrica. Os dados foram submetidos a ANOVA e aos testes de Tukey e Dunnett (5 por cento). Os tratamentos alopático e homeopático levaram a formação óssea de aspecto diferente considerando a remodelação e maturação. Mais pesquisas são necessárias para avaliar a resistência e qualidade do osso neoformado.


Subject(s)
Animals , Male , Rats , Bone Density Conservation Agents/therapeutic use , Bone Remodeling/drug effects , Calcium Phosphates/therapeutic use , Etidronic Acid/therapeutic use , Osteoporosis/drug therapy , Phytotherapy , Analysis of Variance , Bone Density Conservation Agents/pharmacology , Bone Density/drug effects , Calcium Phosphates/pharmacology , Disease Models, Animal , Etidronic Acid/analogs & derivatives , Orchiectomy , Osteoporosis/pathology , Plant Preparations
SELECTION OF CITATIONS
SEARCH DETAIL